Hitpass, L.; Amygdalos, I.; Sieben, P.; Raaff, V.; Lang, S.; Bruners, P.; Kuhl, C.K.; Barabasch, A.
MRI-Based Quantitation of Hepatic Steatosis Does Not Predict Hypertrophy Rate after Portal Vein Embolization in Patients with Colorectal Liver Metastasis and Normal to Moderately Elevated Fat Fraction. J. Clin. Med. 2021, 10, 2003.
https://doi.org/10.3390/jcm10092003
AMA Style
Hitpass L, Amygdalos I, Sieben P, Raaff V, Lang S, Bruners P, Kuhl CK, Barabasch A.
MRI-Based Quantitation of Hepatic Steatosis Does Not Predict Hypertrophy Rate after Portal Vein Embolization in Patients with Colorectal Liver Metastasis and Normal to Moderately Elevated Fat Fraction. Journal of Clinical Medicine. 2021; 10(9):2003.
https://doi.org/10.3390/jcm10092003
Chicago/Turabian Style
Hitpass, Lea, Iakovos Amygdalos, Paul Sieben, Vanessa Raaff, Sven Lang, Philipp Bruners, Christiane K. Kuhl, and Alexandra Barabasch.
2021. "MRI-Based Quantitation of Hepatic Steatosis Does Not Predict Hypertrophy Rate after Portal Vein Embolization in Patients with Colorectal Liver Metastasis and Normal to Moderately Elevated Fat Fraction" Journal of Clinical Medicine 10, no. 9: 2003.
https://doi.org/10.3390/jcm10092003
APA Style
Hitpass, L., Amygdalos, I., Sieben, P., Raaff, V., Lang, S., Bruners, P., Kuhl, C. K., & Barabasch, A.
(2021). MRI-Based Quantitation of Hepatic Steatosis Does Not Predict Hypertrophy Rate after Portal Vein Embolization in Patients with Colorectal Liver Metastasis and Normal to Moderately Elevated Fat Fraction. Journal of Clinical Medicine, 10(9), 2003.
https://doi.org/10.3390/jcm10092003
